Göran Ando

Göran A. Ando was born on 6 March 1949 and is a Swedish national. Dr Ando is a specialist in General Medicine and a Founding Fellow of the American College of Rheumatology in the US.

Dr Ando is former Executive Vice President and President of Research & Development of Pharmacia Corporation, which was acquired by Pfizer Inc. in 2003. In April 2003, he was appointed CEO of the Celltech Group PLC in the United Kingdom until its acquisition in 2004 by UCB.

Dr Ando is currently Chairman of the Board of Directors of Symphogen A/S, and Vice Chairman of Novo Nordisk A/S and S*Bio Pte Ltd., Singapore. He is also a member of the Board of Directors of Nicox SA, EUSA Pharma, EDB Investments Pte Ltd., Molecular Partners, Chroma Therapeutics and Archimedes Pharma.

Dr Ando serves as a Senior Advisor to Essex Woodlands Health Ventures UK Ltd. and is Chairman of the Scientific Advisory Boards of Southwest Michigan First (SWMF). He is also a member of the Scientific Advisory Board of Bausch & Lomb.